Metraipolis › archive › dc_4e51104be859

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in… — Europe PMC PMID:41295522

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41295522
DOI
10.3390/vaccines13111149
License (as archived)
solo-consultazione
Archived
2026-11-08T16:25:43.918Z
SHA-256 of the archived text
7962a7ac74e3b8c67bcbfa950980b1787a8b2a1daad1f6c3d3976967d55883dc
Stable URL of this page
https://metraipolis.com/documento/dc_4e51104be859

How to cite

Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in… — Europe PMC PMID:41295522 — Europe PMC (en), https://europepmc.org/article/MED/41295522 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e51104be859 (Metraipolis archive dc_4e51104be859, sha256 7962a7ac74e3b8c67bcbfa950980b1787a8b2a1daad1f6c3d3976967d55883dc)
BibTeX
@misc{dc4e51104be859,
  title = {Immunogenicity and Safety of Half and Full Doses of Heterologous and Homologous COVID-19 Vaccine Boosters After Priming with ChAdOx1 in Adult Participants in… — Europe PMC PMID:41295522},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41295522},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e51104be859; sha256 7962a7ac74e3b8c67bcbfa950980b1787a8b2a1daad1f6c3d3976967d55883dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41295522. Agents can read the archived copy with the MCP tool read_document.